60 Degrees Pharmaceuticals, Inc. (SXTP): Total Liabilities
$1.99M
As of 2025-12-31
$2.34M
As of 2026-09-30
-57.3%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.99M | +10.1% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $1.80M | -39.6% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $2.99M | -88.3% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $25.45M | n/a | 2024-04-01, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $1.99M | +10.1% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $8.64M | -24.4% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $29.63M | +5.4% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $5.05M | -18.9% |
| Rafael Holdings, Inc. (RFL) | 2026-07-31 | $11.09M | -29.6% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $4.11M | -57.1% |
| Rallybio Corp (RLYB) | 2025-12-31 | $4.30M | -33.3% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.59M | +24.9% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $9.16M | -50.7% |
Compare SXTP, STTK, DARE, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗